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Table 1. Patients with nontyphoidal salmonella ovarian abscesses
Case (Ref) Age Salmonella
Species
Ovarian
Pathology
Salpingitis Preceding Time Between 
Event Event and
Diagnosis
Blood/Stool
Culture
l5 19 paratyphi A Dermoid cyst No Enterocolitis Coexisted + / —
26 30 brandenburg Endometriotic
cyst
No Enterocolitis 6 months
34 25 enteritidis Bilateral
abscesses
Yes Enterocolitis Not stated + / -
47 28 Stanley Endometriotic
cyst
Yes Enterocolitis 1 week —/ +
58 42 typhimurium Cyst Yes Osteomyelitis 3 years 
Urinary 1 year 
infection
- / -
69 25 newport Cyst Yes Enterocolitis 1 week - / -
710 43 panama Endometriotic
cyst
Yes Nil - - / -
8 (present) 31 enteritidis Bilateral
abscesses
Endometriosis
Yes Nil (prior — 
bacteremia 
with different 
salmonella)
- / + *
* Stool culture grew different salmonella species to that in the ovarian abscess.
trast with the general population, patients with SLE need eradication treat­
ment for asymptomatic salmonella carriers14.
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Inclusion Body Myositis Responding 
to Longterm Chlorambucil Treatment
To the Editor:
Inclusion body myositis (IBM) is known for its poor response to immuno­
suppression1' 5, Yet recent retrospective studies indicate that some patients 
may benefit from prolonged treatment with methotrexate (MTX), azathio- 
prine or cyclosporine in combination with prednisone6»7. In a patient with 
IBM who was resistant to these immunosuppressive drugs, we prospectively 
studied for 3 years the effects of chlorambucil and low dose prednisone.
Our patient, a 53-year-old woman, noticed a slowly progressive weak­
ness of legs and arms in 1987. Examination showed proximal weakness
• of both legs. Rheumatoiogical and dermatological evaluation was normal. 
Serum creatine kinase (CK) concentration was 5200 U/l. Electromyography 
suggested an inflammatory myopathy. Light microscopy of paraffin embed­
ded sections of quadriceps muscle biopsy showed atrophic fibers, necro­
sis, mononuclear cell infiltration, and vacuoles without basophilia. Poly­
myositis was diagnosed and prednisone (1 mg/kg/day) was given for 6 weeks, 
and then tapered. Because of further progression she was transferred to our 
hospital. We found a symmetric weakness (Medical Research Council, MRC) 
grade 4.5 of all 4 limbs, proximal and distal. A steroid resistant polymyo­
sitis was diagnosed. For subsequent treatments and serum CK values see 
Figure 1. Addition of azathioprine (150-250 mg/day) or MTX (20-30 
mg/week) to prednisone (20 mg/day) did not stop the slow progression. 
Cyclosporine (4-6 mg/kg/day) with prednisone (20 mg/day) did stabilize 
her muscle strength for 1 month, but had to be discontinued after 5 weeks 
because of intractable side effects. She underwent lymphapheresis (2/week) 
with MTX (30-35 mg/week) and prednisone (20 mg/day) for 10 weeks, 
but muscle strength and activities of daily living were impaired further. Light
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Fig. 7. Serum concentrations of CK during various immunosuppressive treatments; high dose prednisone (pred), azathioprine (aza), methotrexate (mtx), 
cyclosporine (cs), lymphapheresis (lymph), cyclophosphamide (cycloph), and chlorambucil.
microscopy of a 2nd quadriceps muscle biopsy (hematoxylin eosin stained 
fresh-frozen transverse 8 /¿m sections) showed lymphocyte infiltrations, 
necrotic muscle fibers, myophagia, and rimmed basophilic vacuoles. Elec­
tron microscopy showed scarce 16 nm filaments in the cytoplasm, close 
to glycogen and lysosomes. IBM was diagnosed. Cyclophosphamide 
(500-1000 mg/week iv for 12 weeks) gave an initial stabilization, but muscle 
weakness worsened in the 2nd mo. On a 2nd trial of prednisone (80-45 
mg/day for 6 mo) serum CK levels decreased to 1500 U/l, but clinical de­
terioration continued.
At that time, August, 1990, we started chlorambucil 0.1 mg/kg/day (8 
mg/day). Prednisone dose (30 mg/day) was lowered by 2.5 mg/mo. Before 
and during this treatment, muscles with MRC grade 4 had the maximal volun­
tary contraction force measured on a hand held strain gauge dynamometer8. 
Addition of maximal voluntary contraction force values yielded the muscle 
force sum score. For MRC grade 3 muscles, not quantifiable on dynamo- 
metry, the MRC mean value was calculated.
Chlorambucil was well tolerated. After 2 mo, the patient and her family 
noticed a slight improvement of walking. For this reason we continued chlor­
ambucil and after 7 mo, when the prednisone dose was 20 mg/day, she had 
a more stable gait, could rise from a high chair without assistance, and was 
capable of some housekeeping and driving a car. Improvement continued 
slowly for the next 8 mo; during this period prednisone was tapered to 10 
mg/day. Then her condition stabilized. After 1 yr chlorambucil was lowered 
to 6 mg/day. During the 3rd yr it was decreased by 2 mg/day/4 mo. After 
3 yr chlorambucil was stopped. To date her condition is unchanged. Results 
of muscle testing are given in Table 1.
We think that chlorambucil contributed essentially to this patient’s im­
provement, since the changes were temporally related to the administra­
tion of chlorambucil. Although the serum CK concentrations decreased dur­
ing the regimen of high dose prednisone, they did not reach normal values. 
Moreover, in myositis a decrease of CK values during prednisone does not 
imply a steroid responsiveness of the inflammation9, and indeed in our 
patient CK levels remained elevated, indicating continuing disease activity. 
The last high dose prednisone trial might have led to a steroid myopathy. 
If so, the improvement with chlorambucil could have resulted from pred­
nisone taper. However, the steady deterioration in muscle strength before 
and during high dose prednisone argues against this explanation.
Vacuolar myopathy may have various causes10. Although the findings 
on electron microscopy were not typical11, we think that IBM diagnosis 
is most probable, given the resistance to previous immunosuppression and 
the characteristic findings on light microscopy3. In fact, filamentous inclu* 
sions may be absent in as many as 25 to 70% of patients with IBM2.
Recently, a retrospective study reported that 12 of 28 patients, having 
received some sort of immunosuppression, experienced delayed progres­
sion, and 3 exhibited longterm improvement6. The responding patients were 
treated with MTX, azathioprine, or cyclosporine, in combination with pred­
nisone. In our patient the clearly positive effects of chlorambucil appeared 
after 7 mo. Perhaps azathioprine or MTX would also have been effective, 
if given for more than 3 mo. In 1 patient normalization of muscle strength 
and CK concentration occurred after 2 years of taking azathioprine and low 
dose prednisone12. Our observation confirms the view that, given the chro- 
nicity and the slow progression in IBM, trials of 3 mo may not be long
Table 1. Results of MRC grading of muscle strength (MRC mean) and of dynamometry 
(muscle force sum score, MFSS), and daily doses of chlorambucil and prednisone
MRC Mean MFSS Chlorambucil Prednisone
(mg) (mg)
p < 0.04 compared to pretreatment value.
Letters
Pretreatment 2.6 ± 0.5 88.5 ±38.1  — 35
After 1 yr 3.0 ± 0.6* 94.4 ± 42.0 8 15
2 yrs 3,0 ± 0.7* 96.3 ± 47.4 6 -
3 yrs 3.1 ±  0.7* 99.4 ± 52.6
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enough to yield clinical results3. Therefore, we judge it reasonable in
progressive IBM to consider a longterm trial with a cytotoxic agent, such
as chlorambucil, possibly in combination with low dose prednisone.
University Hospital Nijmegen, Peter J.H. Jongen, MD;
Nijmegen, The Netherlands. Henk J. ter Laak, PhD;
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Moraxella Septic Arthritis in an Adult
To the Editor:
A 50-year-old white woman, an office worker, developed pain and swell­
ing in the right elbow on April 26, 1993. She consulted an orthopedist in 
May, who aspirated cloudy white fluid which clotted. Differential count 
showed 97% neutrophils. Cultures were sterile after I week. Routine radio­
graphy showed only soft tissue swelling: a technetium 99m diphosphonate 
bone scan showed diffuse uptake about the right elbow. Blood counts were 
within normal limits. She was seen in consultation by a rheumatologist on 
December 5, 1993 who noted a 30° flexion contracture and warm reddened 
skin over the right elbow. Vital signs, including temperature were normal. 
Aspiration of a highly viscous fluid was followed by injection of 40 mg
of triamcinolone hexacetonide. A total leukocyte count could not be done 
because of cell clumping; 91 % of cells were neutrophilic leukocytes. There 
were no organisms by gram stain and no crystals by polarized light micro­
scopy. Again there was no growth of organisms in either aerobic or anaerobic
cultures.
By May 17, 1993, pain and swelling had subsided greatly, and she returned 
to work. When seen on May 19, the contracture had decreased to 10°. Aspi­
rated fluid, however, contained 173,500 leukocytes/mm3, 94% neutrophils. 
Serum amylase and lipase levels were normal. Skin tests for purified pro­
tein derivative, mumps, histoplasmin, coccidioidin, and Trichophyton were 
completely negative at 48 and 72 h. Culture on Columbia agar with 5% 
sheep red blood cells and chocolate agar grew rare gray colonies of small 
gram negative oxidase positive rods. Identification and minimal inhibiting 
concentration tests were performed using the Microscan Walkaway 40 Sys­
tem (Baxter Microscan, Sacramento, CA). The organisms failed to grow 
on the negative combination type 2 panels on 2 attempts. A Fox Fastidious 
panel (Medical Specialties Inc., Cleveland, OH) was used, but again the 
organisms failed to grow. Identification of the organism was performed using 
the API NFT (BioMenieux Vitek Inc, Hazelwood, OH). After 48 h incu­
bation, profile 0000004 was obtained. The organism was nonmotile, grew 
at 42°C, and was reported as a species of Moraxella. There was insuffi­
cient growth for further characterization or for antibiotic sensitivity test­
ing. Cultures for mycobacteria and fungi were negative.
Ciprofloxicin 1 g twice daily was begun on May 26 and continued for 
14 days, at which time the affected joint was perfectly normal. This agent 
was chosen because its broad specificity includes Moraxella species. Fol- 
lowup 2 months later revealed no residual abnormalities. Repeat skin tests 
confirmed that the patient was anergic, but T cell subsets revealed no abnor­
malities. The helper to suppressor ratio was 1.9. A mild polyclonal increase 
in gamma globulin was noted (1.87 g/dl; normal 0.7-1 .6 g/dl) due to an 
increased IgG level (1730 mg/dl; normal 700-1500 mg/dl).
History revealed hypothyroidism treated with daily thyroid hormone 
replacement, an ovarian abscess, and an axillary abscess many years earlier, 
a urinary tract infection treated in 1989, 2 episodes of afebrile otitis media 
treated with a cephalosporin antibiotic in January and October, 1991. In 
November, 1991 she had developed severe left pleuritic pain accompanied 
by a small persistent pleural effusion and a nonproductive cough. She was 
short of breath but had no chills or fever. Symptoms lessened but did not 
disappear coincident with a 10-day course of amoxicillin. The left pleural 
effusion, now loculated, persisted in films taken as late as May 25, 1993 
as did persistent, intermittent, left costovertebral angle pain. Another afebrile 
pulmonary episode consisting of shortness of breath and cough described 
as “ asthma-like” in December, 1992 by her primary care physician was 
treated with cephalosporin and a clonidine patch for smoking cessation 
(patient complied with this effort). A 10-day course of penicillin was given 
for a sore red throat in January, 1993.
Kingella species, a genus in the Neisseriacae family, were known until 
1974 as Moraxella and before that as Mimae polymorphaK Most (86%) 
cases of bone and joint infection occur in infants or children under age 4 
years, Upper respiratory symptoms precede these infections in 31% of cases. 
Pain and swelling usually develop insidiously in large joints; 4 of the 29 
cases discussed in one review, like our patient, had no fever1. The 4 previ­
ous reports of kingella joint sepsis in adults are outlined in Table I2' 5.
Table 1. Reported cases o f  septic arthritis due to Kingella in adults
AggReference Sex Joint Fever Other
422 F Both wrists + 104°F Rash, vaginitis, conjunctivitis
493 M Knee -t-105°F Bartender; ethanol abuse
514 F Elbow Rheumatoid arthritis, leukopenia; (Felty’s 
syndrome)
765 M Knee — Chronic bronchitis; emphysema
50* F Elbow — Prior pleurisy and otitis media; anergic
* Current case.
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